IRIS
Parravano, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.319
NA - Nord America 1.728
SA - Sud America 968
EU - Europa 257
AF - Africa 150
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.429
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.581
SG - Singapore 881
BR - Brasile 710
CN - Cina 436
HK - Hong Kong 293
VN - Vietnam 169
MX - Messico 103
IN - India 97
IT - Italia 96
AR - Argentina 89
BD - Bangladesh 83
IQ - Iraq 46
ID - Indonesia 41
MA - Marocco 39
TR - Turchia 38
CO - Colombia 37
EC - Ecuador 35
PH - Filippine 33
PK - Pakistan 33
RU - Federazione Russa 31
SA - Arabia Saudita 31
ZA - Sudafrica 31
UZ - Uzbekistan 26
VE - Venezuela 26
GB - Regno Unito 25
TN - Tunisia 23
CL - Cile 20
PY - Paraguay 20
FR - Francia 19
MY - Malesia 18
DE - Germania 15
NL - Olanda 14
PE - Perù 12
UA - Ucraina 12
CA - Canada 11
JO - Giordania 10
NP - Nepal 10
EG - Egitto 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BO - Bolivia 8
ES - Italia 8
KZ - Kazakistan 8
ET - Etiopia 7
KE - Kenya 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
JM - Giamaica 5
LB - Libano 5
PS - Palestinian Territory 5
QA - Qatar 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
IL - Israele 4
OM - Oman 4
PA - Panama 4
PL - Polonia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BW - Botswana 3
CG - Congo 3
GT - Guatemala 3
IE - Irlanda 3
KG - Kirghizistan 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
AT - Austria 2
BH - Bahrain 2
GE - Georgia 2
GR - Grecia 2
HT - Haiti 2
IR - Iran 2
KH - Cambogia 2
KR - Corea 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MN - Mongolia 2
MR - Mauritania 2
MW - Malawi 2
MZ - Mozambico 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RE - Reunion 2
RO - Romania 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
YE - Yemen 2
AD - Andorra 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
Totale 5.401
Salva come PNG Salva come JPEG
Città #
San Jose 1.012
Singapore 476
Ashburn 334
Hong Kong 287
Beijing 230
Mexico City 76
Ho Chi Minh City 56
São Paulo 49
Hanoi 33
Rome 30
Rio de Janeiro 21
Tashkent 21
Belo Horizonte 20
Santa Clara 19
Guayaquil 16
Medellín 16
Baghdad 14
Dhaka 14
Curitiba 13
Campinas 11
Da Nang 11
Porto Alegre 11
Quito 11
Salvador 11
Caracas 10
Jakarta 10
Johannesburg 10
Riyadh 10
Brasília 9
Casablanca 9
Hải Dương 8
Jeddah 8
Lahore 8
Lima 8
New York 8
Tunis 8
Amman 7
Caxias do Sul 7
Chandigarh 7
Istanbul 7
Rabat 7
Ankara 6
Asunción 6
Betim 6
Cali 6
Goiânia 6
Haiphong 6
Milan 6
Montevideo 6
Ninh Bình 6
Santiago 6
Addis Ababa 5
Alvorada 5
Amsterdam 5
Aryanah 5
Blumenau 5
Can Tho 5
Dammam 5
Delhi 5
Doha 5
João Pessoa 5
Karachi 5
Kuala Lumpur 5
Lucknow 5
Mumbai 5
Nairobi 5
New Delhi 5
Orem 5
Rosario 5
Anápolis 4
Araraquara 4
Baku 4
Baltimore 4
Bauru 4
Belém 4
Cape Town 4
Córdoba 4
Feira de Santana 4
Florianópolis 4
Hyderabad 4
Jaraguá do Sul 4
Karbala 4
Kathmandu 4
Kingston 4
Kyiv 4
Los Angeles 4
Ludhiana 4
Manila 4
Maringá 4
Marrakesh 4
Medina 4
Nova Iguaçu 4
Panama City 4
Pelotas 4
Petrópolis 4
Ribeirão Preto 4
Salé 4
San José 4
Santa Maria 4
Sobral 4
Totale 3.207
Salva come PNG Salva come JPEG
Nome #
DRCR.net Trials for Diabetic Macular Edema 56
Towards a better understanding of non-exudative choroidal and macular neovascularization 45
Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis 44
Association between Visual Impairment and Depression in Patients Attending Eye Clinics: A Meta-analysis 42
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 39
Citicoline and Vitamin B12 Eye Drops in Type 1 Diabetes: Results of a 36-Month Pilot Study Evaluating Macular Electrophysiological Changes 38
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials 38
Ocular Biomarkers for Alzheimer Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses 35
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials 35
Use of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) questionnaires for clinical decision-making and psychological referral in ophthalmic care: A multicentre observational study 35
Author Correction: Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes (Scientific Reports, (2020), 10, 1, (18266), 10.1038/s41598-020-75416-8) 34
A gender-based analysis of retinal microvascular alterations in patients with diabetes mellitus using OCT angiography 34
USING THREE-DIMENSIONAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY METRICS IMPROVES REPEATABILITY ON QUANTIFICATION OF ISCHEMIA IN EYES WITH DIABETIC MACULAR EDEMA 33
Optical Coherence Tomography Angiography Findings in Active and Inactive Ocular Behçet Disease 32
Health Technology Assessment Report on Lucentis. 32
Survival and Health Care Burden of Children with Retinoblastoma in Europe 32
Early and localized retinal dysfunction in patients with type 1 diabetes mellitus studied by multifocal electroretinogram 32
A Novel Algorithm for the Evaluation of Corneal Nerve Beadings by in vivo Confocal Microscopy in Patients With Type 1 Diabetes Mellitus 32
ANALYSIS OF RETINAL CAPILLARIES IN PATIENTS WITH TYPE 1 DIABETES AND NONPROLIFERATIVE DIABETIC RETINOPATHY USING ADAPTIVE OPTICS IMAGING 31
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 31
Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison 31
Progression Biomarkers of Microvascular and Photoreceptor Changes Upon Long-Term Evaluation in Type 1 Diabetes 30
A custom-made semiautomatic analysis of retinal nonperfusion areas after dexamethasone for diabetic macular edema 30
Quality of vision index: A new method to appraise visual function changes in age-related macular degeneration 30
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers 29
Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy 29
Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience 29
Effectiveness of a Hydrophilic Curcumin-Based Formulation in Coadjuvating the Therapeutic Effect of Intravitreal Dexamethasone in Subjects With Diabetic Macular Edema 29
Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion 29
Early and Late Morphological and Functional Changes After Verteporfin Photodynamic Therapy 29
Vision-related quality of life in patients treated for myopic choroidal neovascularization: A post hoc analysis of the OLIMPIC study 29
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design 28
Health Tecnology Assesment del farmaco ranibizumab (Lucentis) 28
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 28
NONEXUDATIVE INTRARETINAL FLUID IN INTERMEDIATE AGE-RELATED MACULAR DEGENERATION 28
Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice 28
Macular functional and morphological changes in intermediate age-related maculopathy 28
A COMMON FINDING IN FOVEAL-SPARING EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN IMPLICATES BASAL LAMINAR DEPOSITS 28
Effects of circadian rhythm disruption on retinal physiopathology: Considerations from a consensus of experts 28
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report 28
OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study 28
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy 27
Psychological profile and distinct salivary cortisol awake response (Car) in two different study populations with obstructive sleep apnea (osa) and central serous chorioretinopathy (csc) 27
Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab: 24-month results 27
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials 27
A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose 27
Characteristics and Spatial Distribution of Structural Features in Age-Related Macular Degeneration: A MACUSTAR Study Report 27
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY ASSESSMENT OF THE DIABETIC MACULA: A Comparison Study Among Different Algorithms 27
Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study 27
Retinal Displacement after Idiopathic Macular Hole Surgery: Layer by Layer Analysis 27
Leveraging Optical Coherence Tomography and Angiography Artifacts to Identify Clinicopathological Correlates in Macular Disorders 27
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials 27
Relationship of Choroidal Vasculature and Choriocapillaris Flow with Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy 27
ADAPTIVE OPTICS IMAGING OF PARAFOVEAL CONES IN TYPE 1 DIABETES 27
Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update 27
The “triple-layer sign”: an optical coherence tomography signature for the detection of non-exudative macular neovascularization 27
Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length 27
Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report 27
Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants 27
Anatomical and functional changes in neovascular AMD in remission: comparison of fibrocellular and fibrovascular phenotypes 27
Author Correction: Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report (Scientific Reports, (2022), 12, 1, (21911), 10.1038/s41598-022-26223-w) 27
Pilot study to evaluate the efficacy and safety of pneumatic trabeculoplasty in glaucoma and ocular hypertension 26
Gene therapy in retinal dystrophies 26
Whole Genome Sequencing Solves an Atypical Form of Bardet–Biedl Syndrome: Identification of Novel Pathogenic Variants of BBS9 26
Utility values and electronic device use in low-vision people attending rehabilitation services: Data from a nation-wide registry in Italy 26
Argon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatment 26
Profile of non-responder and late responder patients treated for diabetic macular edema: systemic and ocular factors 26
Microperimetric retinal changes in myopic choroidal neovascularization treated with intravitreal ranibizumab 26
Rheopheresis in vascular diseases 26
Reticular pseudodrusen characterization by retromode imaging 26
Differences in cysts characteristics and related influence on the anatomical response after dexamethasone implant in diabetic macular oedema 26
Photodynamic therapy with verteporfin for chronic central serous chorioretinopathy: A review of data and efficacy 26
Appearance of cysts and capillary non perfusion areas in diabetic macular edema using two different OCTA devices 26
Guidelines on Optical Coherence Tomography Angiography Imaging: 2020 Focused Update 26
Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries? 26
Functional Correlates of Outer Retina Remodeling in Intermediate Age-Related Macular Degeneration Using Microperimetry 26
OCT retinal angiography features in patients with rheumatoid arthritis: A pilot study 26
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients 26
Deep learning for automatic prediction of early activation of treatment-naive nonexudative macular neovascularizations in age-related macular degeneration 26
Imaging biomarkers of 1-year activity in type 1 macular neovascularization 26
Resilience of the Photoreceptors in Posterior Multifocal Placoid Pigment Epitheliopathy Observed by Microperimetry over Time 25
Influence of Disc Size on Optic Nerve Head versus Retinal Nerve Fiber Layer Assessment for Diagnosing Glaucoma 25
Photodynamic Therapy in Subfoveal and Juxtafoveal Myopic Choroidal Neovascularization: A 10-year Retrospective Analysis 25
Choroidal neovascularization in angioid streaks and pseudoxanthoma elasticum: 1 year follow-up 25
Metabolic, Microvascular, and Structural Predictors of Long-Term Functional Changes Evaluated by Multifocal Electroretinogram in Type 1 Diabetes 25
Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug 25
Targeting immunoproteasome in neurodegeneration: A glance to the future 25
Multimodal Study of PRPH2 Gene-Related Retinal Phenotypes 25
Branch retinal artery occlusion caught in the act by an optical coherence tomography angiography image: case report 25
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes 25
Prioritizing Questions and Outcomes for Guidelines on Age-Related Macular Degeneration Moving Beyond the Clinical Encounter 25
RETINAL FUNCTIONAL CHANGES MEASURED BY MICROPERIMETRY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS TREATED WITH RANIBIZUMAB 25
SUBRETINAL LIPID GLOBULES AN EARLY BIOMARKER OF MACULAR NEOVASCULARIZATION IN EYES WITH INTERMEDIATE AGE-RELATED MACULAR DEGENERATION 25
The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies 25
The role of advanced structural and functional retinal testing in the diagnosis of early retinopathy in type 1 diabetes 25
Characterisation of macular neovascularisation in geographic atrophy 25
Author Response: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy 25
Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial 24
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine 24
Macular versus Retinal Nerve Fiber Layer Parameters for Diagnosing Manifest Glaucoma A Systematic Review of Diagnostic Accuracy Studies 24
Totale 2.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.425 0 0 0 0 5 137 123 177 55 53 440 435
2025/20264.244 239 8 378 333 511 295 504 280 1.243 453 0 0
Totale 5.669